Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.
Audio, Transactions of the IRE Profess... 88(10):1194-202 (2009) PMID 19935373
In combination with everolimus (EVL), cyclosporine A (CsA) may be used at low exposure, so reducing the risk of renal dysfunction in renal transplant recipients (RTR). We evaluated whether higher exposure of EVL could allow a further reduction of CsA.
DOI: 10.1097/TP.0b013e3181bb43ec
Version: za2963e q8za6 q8zbb q8zc3 q8zd9 q8zee q8zf5 q8zg7